United States HR 7032: Increasing Transparency in Generic Drug Applications Act of 2022

Status: Referred to the Subcommittee on Health. (as of 2022-03-10)

State: United States · Session: 117 · Bill: HR 7032

Sponsors: Ann M. Kuster, Kim Schrier

View United States HR 7032 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.